PhD
Fred Eshelman Distinguished Professor
Chair, Division Pharmacoengineering & Molecular Pharmaceutics
UNC-Chapel Hill
Molecular Therapeutics
Area of Interest
Kristy Ainslie, PhD, applies her knowledge base in biomaterials and immunology to develop new immune-modulatory therapies that treat and prevent infectious and autoimmune diseases as well as cancer.
Her lab aims to design practical and innovative formulations, taking into account the scalable production and applications in developing nations.
Find publications on Google Scholar
Awards and Honors
- Sato Memorial International Award, 2023
- Controlled Release Society Fellow, 2022
- American Institute for Medical and Biological Engineering (AIMBE) Fellow, 2021
- OSU Council of Graduate Students James M. Siddens Distinguished Faculty Advising Award, 2012
